Member Info for countingcards

This website is offcially pants! They can remove this post, but I am absolutely determine to get it it done for the fourth time of asking through all the ads, and crashes asking for 'reload the page.' Even after telling them they say change browser! As I type advert after advert turns up and even though I run software to minimise it, its still causing issues,

OK for the record, I had bought on AIM, PSL in Jan 2019, In April 2019 PSL became a cash shell, Bould Opportunities PLC with the aim of seeking out a suitable RTO target. In Oct 2019 it was delisted as the target was not completed and due to the rules on AIM and also FCA dithering the deadline was not achieved. While delisted the FCA continued to delay the issues, needing more clarification, and then COVID kicked in March 2020. In April 2020 it was cancelled off AIM. 577 days later a target was announced and Bould came back as Cizzle Biotechnology PLC on the LSE MAIN MARKET.

Believe me it was painful waiting and having the money tied up but due to the lack of knowledge from the FCA on what BOU were trying to achieve and then a backlog because of Covid. Still holding although not posting as very little on the news right now but confident. I am comparing it with SPC because its mirror imaging that situation.

Very confident despite what Peter Jay has said it will return. He has only said it will be cancelled off AIM as that was the question asked, The requirement is to get it on the Main Market which is the real goal. The issue I am confident is with the FCA.

LSE please get the ad bombardment issues sorted!

Well said Philmcccrotch. Its just short of knowing what time the poster in question got up and what was for breakfast? but its getting there! Once or twice OK, but to make it a personal blog, that's something else. Anyways hope this helps.

https://www.ft.com/content/0b4be1bc-1790-49bc-b5c6-bfff2e52e02b

https://www.cnbc.com/2022/01/21/singapore-spac-ipo-for-pegasus-asia-backed-by-european-investors.html

Singapore’s second SPAC made its debut on Friday — and a third one is on its way
Published Fri, Jan 21 20221:24 AM EST Updated Fri, Jan 21 20221:48 AM EST

https://www.ft.com/content/37a48ffb-59b4-446f-98f5-723f6864ddd6

Gary Cohn-backed Spac to take lottery operator public in $9.3bn listing

A blank cheque company backed by Gary Cohn, the former Goldman Sachs president and Trump administration adviser, plans to take a group bidding to run the UK’s National Lottery public in a $9.3bn listing on Wall Street.

Steady positive progress, all round. Funding sorted and looking forward to a great 2022.

This is how I have read it as well. That ratification is only to approve and validate what has been already been issued. However they are also asking for consideration to approve the possibility of issuing further shares to the amount of 10% of the total. That does not mean they are going to be issued but simply a mechanism available if need be.

The concern is that should that be triggered early, say within the next few months, then if there has been no significant improvements up till then like pending deals, alarms bells will be ringing. I am involved in another stock on the NASDAQ which has successfully raised over 10 times and is sitting on a massive pile of cash that should it be closed tomorrow it would pay back 100% on the holding. It also has smartly been buying other competitors with cash. So its now down to MXC to start the PR machine and get updates out. Otherwise it will begin to look like nothing has changed from the past, and that they raise cash, make promises and keep kicking the can down the road, The other concern is most of the companies they seem to be dealing with gives the impression that there is an incestuous culture. A lot of crossover to companies where the directors names also appear.

Willing to give them a little more time, otherwise any holding can be deployed sensibly elsewhere. Code red has not been triggered yet, but getting a little concerned.

https://www.pkf-l.com/wp-content/uploads/2021/11/A-catch-up-with-November-2021.pdf

Page 10
Roby Zumer

https://one.com.mt/?s=Mgc+pharma

https://businesscann.com/mgc-pharmaceuticals-tells-shareholders-pending-deal-could-transform-finances-overnight/

https://mgcpharma.com.au/investor-centre/news-media/

Everything you need to know before listing, and post. 2015 to roughly 18.02.2021.

One theory is this:
2nd September 2021. You announce MGC Pharmaceuticals Limited CimetrA import approval granted in India

8th September you place an inside 'short' at close the hghest price on the day achieveable. Maybe because it has been decided a placement is due down the line and the price is getting away too quick, and a higher placement price will not attract interest, so to make it attractive send out as much negative vibes as possible, play down MXC, say it has no future, beat on about competition, and get the price down as close the placement price of 2p, at least before 2nd December.

All this has to be done by 2nd December which is the 90 day period to the news on India. So no matter what buys come in you match it with a similar sell, to keep the price in check. Its no big deal as once you get the placement announcement done, you close out the inside 'short' for maybe 2.3p? as seen today? and bank 1p for your troubles? and now the stage is set - the news arrives, no more significant seller, just open road back to previous high first, and then the herd take care of the rest.

That's the theory anyway. Anyone got a better one?

So its 90 days to news on India? Which just happens to be 2nd December? Which just happens to be "The Company requests that the trading halt end on the earlier of the commencement of normal trading on Thursday 2 December 2021, or when the announcement referred to above is released to the market.

A placing? So now it makes sense why those rather large buy trades were going through all day.

The same reason IBM laughed off Microsoft over something called a 'mouse' a device used to navigate around a computer interface. IBM when they DID want to move were so adapted to their own techs they could not adapt fast enough, and ths became the dinosaur of our age. They came to regret that decision. Now who is laughing?

MXC is simply a component in a growing area, and its the public demand that sways decision making ultimately and pressure is being applied as we speak. MXC is not interested in GSK and GSK are not even remotely interested in MXC. How do I know? there is nothing in the public domain.

A 19% loss going on to 20% really tells everything I need to know about that poster. Maybe if they changed one component of their investing strategy they will also be successful or remain a dinosaur.

Thanks Metalbasher, and thanks for your previous posts.

https://www.youtube.com/watch?v=LldcjNLVFcc&ab_channel=CannabisEuropa
Video is over 7 hours long.

Roby speaks from 6hrs mark onwards.

https://bermele.com/app/uploads/2021/06/Juniper-Prospectus-Locked.pdf

Aberdeenman

There are currently 222m shares, and suspension price was around 0.75p? Giving a current suspended market cap of £1.67m.

We don’t know what the placing price was although it has been oversubscribed, and it was to raise £3m by way of 30m new shares. The Times article 2nd June 2021 highlighted around 10p per share which equates correctly to the placing.

How are you then working out a consolidation of 10:1 (has this been indicated anywhere?) based on 222m old shares plus 30m new shares and coming to a price of 1p on relist?

thank you.

RNS Number : 6470D
Bermele PLC
30 June 2021


For Immediate Release 30 June 2021

Bermele Plc

("Bermele" or "the Company")

Proposed Acquisition of East Imperial Pte. Ltd.

Proposed Re-Admission of the Enlarged Share Capital to the Official List (by way of Standard Listing under Chapter 14 of the Listing Rules) and to trading on the London Stock Exchange's main market for listed securities

Conditional fundraise of £3 million

Proposed Change of Name to East Imperial PLC

Notice of General Meeting

Bermele Plc is pleased to announce a number of proposals, including the acquisition of East Imperial Pte. Ltd. ("East Imperial") and the intention for the Company's shares to be Re-Admitted with Enlarged Share Capital to the Official List (by way of Standard Listing under Chapter 14 of the Listing Rules) and to trading on the London Stock Exchange's main market for listed securities, all of which are subject to shareholder approval at a General Meeting.

Chriszzr

Excellent post and thanks for sharing.

Neilin to correct your post.

Antos held 1966244949 prior as Bould. After consolidation of 500-1, the holding changed to 3932489. Given there were
253,447,788 new shares under Cizzle, that would give AG a new holding of 1.55% (without warrant conversion). There would therefore be no need for declaration as it falls below the new 3% threshold.

I would expect you will do the calculations yourself and confirm that what is said here is correct?

I thought it correct to post this, so as to prevent mass confusion and worries etc.

Thanks.

All current work paid for(£1m). Plus up to £5m paid in royalties and further royalties on use of the companion drug. This is the kind of exposure CIZ is going to get and this today marks the confidence in them. Well done.